Target intelligence / Profile preview

TatD DNase domain containing 2 pseudogene 3 (TATDN2P3)

Target
TATDN2P3
Molecular classification
Pseudogene
01

Overview

TATDN2P3 is a non-coding DNA sequence classified as a pseudogene related to the "TatD DNase domain containing 2" gene. Pseudogenes like TATDN2P3 resemble protein-coding genes in sequence but typically carry mutations, stop codons, or regulatory changes that prevent production of a functional TatD enzyme. While most pseudogenes are considered non-functional relics of evolution, recent research suggests that some pseudogene transcripts may regulate gene expression (for example, by acting as competitive endogenous RNAs or miRNA "sponges"). There is, however, no evidence in the scientific literature that TATDN2P3 plays any protein, enzymatic, receptor, or regulatory function relevant to disease, nor is it a therapeutic target.

Other names
TatD2P3
02

Mechanism of action

Not applicable

03

Biological functions

Generally does not produce functional proteinsPotential regulatory RNA functions (e.g., miRNA decoys, affecting parent gene expression)No experimentally validated biological function for TATDN2P3 specifically
04

Disease associations

Generally not directly involved in diseaseSome pseudogenes may act as regulatory elements in cancer or other diseases via RNA-based mechanismsNo established disease role for TATDN2P3

Beyond the preview

Go deeper on TatD DNase domain containing 2 pseudogene 3 (TATDN2P3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TatD DNase domain containing 2 pseudogene 3 (TATDN2P3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call